TechKnowladge Base |
||
|
The 50% reduction was consistent with the sixteen week continuation standards in trial and while this could also be a reasonable clinical indicator for ongoing use, it could be troublesome for Medicare Australia to administer. Also visit my web page :: http://mel-assessment.com/members/mexicoport0/activity/349064/
|
||
Powered by FogBugz

